What You Should Know About the COVID-19 Vaccine
Carmel Shachar, executive director of the Petrie-Flom Center, talks about the COVID-19 vaccine and who is likely to get it first.
Vaccines
-
Read more: What You Should Know About the COVID-19 Vaccine -
Read more: An Equity-Based Strategy for COVID-19 Vaccine Distribution An Equity-Based Strategy for COVID-19 Vaccine Distribution
Taking a broader, systems-level approach to the distribution of incoming COVID-19 vaccines may drive health equity.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from November 2020.
-
Read more: Challenges in COVID-19 Vaccine Rollout: Lessons from the UK Challenges in COVID-19 Vaccine Rollout: Lessons from the UK
The U.S. can and should cautiously assess the U.K.’s vaccination strategy to avoid challenges that may impede its ability to control the virus.
-
Read more: From “A Spoonful of Sugar” to Operation Warp Speed: COVID-19 Vaccines and Their Metaphors From “A Spoonful of Sugar” to Operation Warp Speed: COVID-19 Vaccines and Their Metaphors
We must remain cognizant of the many ways metaphors may distort, divide, or misrepresent important details.
-
Read more: Benefits and Drawbacks of Emergency Use Authorizations for COVID Vaccines Benefits and Drawbacks of Emergency Use Authorizations for COVID Vaccines
The EUA pathway may impede vital scientific progress needed to establish the long term safety and efficacy of investigational COVID-19 vaccines.
-
Read more: Authorize Emergency Vaccines for COVID-19, but Do It Well Authorize Emergency Vaccines for COVID-19, but Do It Well
We can simultaneously get COVID vaccines to those most at risk while minimizing harm to our ability to fully evaluate their safety and efficacy.
-
Read more: Advance Health Equity by Getting Vaccine Distribution Right Advance Health Equity by Getting Vaccine Distribution Right
Who will get the COVID-19 vaccine soonest, and will those decisions be based on equitable criteria?
-
Read more: COVID-19 and the FDA Emergency Use Authorization Power COVID-19 and the FDA Emergency Use Authorization Power
This blog post provides an overview of the FDA’s emergency authorization powers and analyzes the extent of their usage in the COVID-19 pandemic.
-
Read more: Why the Government Shouldn’t Pay People to Get Vaccinated Against COVID-19 Why the Government Shouldn’t Pay People to Get Vaccinated Against COVID-19
Paying for vaccination is dubious public health policy likely to backfire in terms of (re)building public trust in vaccines.
